Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

306 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[68 Ga]Ga-FAPI-46 PET/CT for locoregional lymph node staging in urothelial carcinoma of the bladder prior to cystectomy: initial experiences from a pilot analysis.
Unterrainer LM, Eismann L, Lindner S, Gildehaus FJ, Toms J, Casuscelli J, Holzgreve A, Kunte SC, Cyran CC, Menold P, Karl A, Unterrainer M, Ledderose ST, Stief CG, Bartenstein P, Kretschmer A, Schulz GB. Unterrainer LM, et al. Among authors: karl a. Eur J Nucl Med Mol Imaging. 2024 May;51(6):1786-1789. doi: 10.1007/s00259-024-06595-z. Epub 2024 Jan 18. Eur J Nucl Med Mol Imaging. 2024. PMID: 38236427 Free PMC article.
Feasibility of [68Ga]Ga-FAPI-46 PET/CT for detection of nodal and hematogenous spread in high-grade urothelial carcinoma.
Unterrainer LM, Lindner S, Eismann L, Casuscelli J, Gildehaus FJ, Bui VN, Albert NL, Holzgreve A, Beyer L, Todica A, Brendel M, Cyran CC, Karl A, Stief CG, Ledderose ST, Unterrainer M, Bartenstein P, Wenter V, Kretschmer A. Unterrainer LM, et al. Among authors: karl a. Eur J Nucl Med Mol Imaging. 2022 Aug;49(10):3571-3580. doi: 10.1007/s00259-022-05761-5. Epub 2022 Mar 24. Eur J Nucl Med Mol Imaging. 2022. PMID: 35325283 Free PMC article.
Radical cystectomy for locally advanced urothelial carcinoma of the urinary bladder: Health-related quality of life, oncological outcomes and predictors for survival.
Volz Y, Grimm T, Ormanns S, Eismann L, Pfitzinger PL, Jokisch JF, Schulz G, Casuscelli J, Schlenker B, Karl A, Stief CG, Kretschmer A. Volz Y, et al. Among authors: karl a. Urol Oncol. 2021 May;39(5):299.e15-299.e21. doi: 10.1016/j.urolonc.2020.10.076. Epub 2020 Nov 10. Urol Oncol. 2021. PMID: 33187885
306 results